NCT01380691View on ClinicalTrials.gov

A Study of LY2216684 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Major Depressive Disorder
Interventions
DRUG

LY2216684

Administered orally

DRUG

Placebo-matching LY2216684

Administered orally

DRUG

Placebo-matching alcoholic beverage

Administered orally

DRUG

Alcoholic beverage

Administered orally

Trial Locations (1)

47710

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01380691 - A Study of LY2216684 in Healthy Participants | Biotech Hunter | Biotech Hunter